Modulation of ageing mice microglia functions during neuroinflammation using synthetic cannabinoids
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.177705 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Akshay Kumar Vijaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Microglia, Aging, Cannabinoids, Neuroinflammatory Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Research Council of Lithuania.
Abstract (Originalsprache)
Ageing is marked by a gradual rise in systemic inflammation, with neuroinflammation being a key feature. Neuroinflammation, which refers to the immune response within the CNS, is primarily mediated by microglia. These resident macrophages in the CNS parenchyma are essential for maintaining homeostasis and initiating immune responses. Their function depends on the timely activation and deactivation of microglia to regulate these processes effectively. Excessive activation of microglia has been shown to disrupt brain functions and promote a proinflammatory response leading to dysfunctional microglia that are unable to carry out immune response due to various reasons, with major implications in neuroinflammation. Therefore, there is a need to monitor and modulate the functionality of microglia to elicit a healthy immune response. The endocannabinoid system is a negative feedback system that is activated to modulate various mechanisms related to inflammation. In our research, we therefore investigated the functionality of microglia in relation to phagocytosis and oxidative stress during neuroinflammation by stimulating the endocannabinoid receptors Cnr1 and Cnr2 with synthetic cannabinoid compounds in ageing mice. Our results show that the expression of the endocannabinoid system (ECS) increases with age. Activation of CB1 and CB2 receptors reduces reactive oxygen species (ROS) in both young and aged mice, with the effect being more pronounced effect in younger mice. In aged mice, the upregulation of these receptors indicates persistent inflammation, while microglial phagocytosis is modulated through CB1 receptors in both age groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257, Vilnius, Lithuania.
- Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257, Vilnius, Lithuania. Electronic address: daiva.baltriukiene@bchi.vu.lt.
- Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257, Vilnius, Lithuania. Electronic address: aurelijus.burokas@gmc.vu.lt.
Förderung
- European Regional Development Fund
- Research Council of Lithuania
Zitieren
APA
Vijaya, A. K., Krisikaitytė, G., Kuras, S., Baltriukienė, D., & Burokas, A. (2025). Modulation of ageing mice microglia functions during neuroinflammation using synthetic cannabinoids. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.177705
Vancouver
Vijaya AK, Krisikaitytė G, Kuras S, Baltriukienė D, Burokas A. Modulation of ageing mice microglia functions during neuroinflammation using synthetic cannabinoids. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.177705
BibTeX
@article{Vijaya2025,
author = {Vijaya, Akshay Kumar and Krisikaitytė, Greta and Kuras, Simonas and Baltriukienė, Daiva and Burokas, Aurelijus},
title = {Modulation of ageing mice microglia functions during neuroinflammation using synthetic cannabinoids},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.177705}
}
EUVIMED